These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 15542374

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope.
    Benferhat R, Martinon F, Krust B, Le Grand R, Hovanessian AG.
    Mol Immunol; 2009 Feb; 46(4):705-12. PubMed ID: 19010547
    [Abstract] [Full Text] [Related]

  • 8. Broad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservation.
    Geels MJ, Dubey SA, Anderson K, Baan E, Bakker M, Pollakis G, Paxton WA, Shiver JW, Goudsmit J.
    J Virol; 2005 Sep; 79(17):11247-58. PubMed ID: 16103177
    [Abstract] [Full Text] [Related]

  • 9. HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha.
    Lekutis C, Shiver JW, Liu MA, Letvin NL.
    J Immunol; 1997 May 01; 158(9):4471-7. PubMed ID: 9127013
    [Abstract] [Full Text] [Related]

  • 10. Studies on the cross-clade and cross-species conservation of HIV-1 Gag-specific CD8 and CD4 T cell responses elicited by a clade B DNA/MVA vaccine in macaques.
    Amara RR, Sharma S, Patel M, Smith JM, Chennareddi L, Herndon JG, Robinson HL.
    Virology; 2005 Mar 30; 334(1):124-33. PubMed ID: 15749128
    [Abstract] [Full Text] [Related]

  • 11. Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach.
    De Groot AS, Jesdale B, Martin W, Saint Aubin C, Sbai H, Bosma A, Lieberman J, Skowron G, Mansourati F, Mayer KH.
    Vaccine; 2003 Oct 01; 21(27-30):4486-504. PubMed ID: 14505932
    [Abstract] [Full Text] [Related]

  • 12. Identification of T cell epitopes by the use of rapidly generated mRNA fragments.
    Britten CM, Meyer RG, Graf C, Huber C, Wölfel T.
    J Immunol Methods; 2005 Apr 01; 299(1-2):165-75. PubMed ID: 15914199
    [Abstract] [Full Text] [Related]

  • 13. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
    Altfeld M, Allen TM, Kalife ET, Frahm N, Addo MM, Mothe BR, Rathod A, Reyor LL, Harlow J, Yu XG, Perkins B, Robinson LK, Sidney J, Alter G, Lichterfeld M, Sette A, Rosenberg ES, Goulder PJ, Brander C, Walker BD.
    J Virol; 2005 Apr 01; 79(8):5000-5. PubMed ID: 15795285
    [Abstract] [Full Text] [Related]

  • 14. Confirmation of immunogenic consensus sequence HIV-1 T-cell epitopes in Bamako, Mali and Providence, Rhode Island.
    Koita OA, Dabitao D, Mahamadou I, Tall M, Dao S, Tounkara A, Guiteye H, Noumsi C, Thiero O, Kone M, Rivera D, McMurry JA, Martin W, De Groot AS.
    Hum Vaccin; 2006 Apr 01; 2(3):119-28. PubMed ID: 17012903
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.
    Zinckgraf JW, Sposato M, Zielinski V, Powell D, Treanor JJ, von Hofe E.
    Vaccine; 2009 Aug 27; 27(39):5393-401. PubMed ID: 19596415
    [Abstract] [Full Text] [Related]

  • 18. Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01.
    Fomsgaard A, Karlsson I, Gram G, Schou C, Tang S, Bang P, Kromann I, Andersen P, Andreasen LV.
    Vaccine; 2011 Sep 16; 29(40):7067-74. PubMed ID: 21767590
    [Abstract] [Full Text] [Related]

  • 19. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
    Borghan MA, Oka S, Takiguchi M.
    Tissue Antigens; 2005 Oct 16; 66(4):305-13. PubMed ID: 16185326
    [Abstract] [Full Text] [Related]

  • 20. Minor components of a multi-envelope HIV vaccine are recognized by type-specific T-helper cells.
    Zhan X, Slobod KS, Surman S, Brown SA, Coleclough C, Hurwitz JL.
    Vaccine; 2004 Mar 12; 22(9-10):1206-13. PubMed ID: 15003649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.